Acute administration of phencyclidine induces tonic activation of medial prefrontal cortex neurons in freely moving rats.
about
GABAergic interneuron origin of schizophrenia pathophysiology.Impaired cognition after stimulation of P2Y1 receptors in the rat medial prefrontal cortex.Spatial and temporal boundaries of NMDA receptor hypofunction leading to schizophrenia.Potentiation of M1 Muscarinic Receptor Reverses Plasticity Deficits and Negative and Cognitive Symptoms in a Schizophrenia Mouse Model.Antipsychotics reverse abnormal EEG complexity in drug-naive schizophrenia: a multiscale entropy analysisNMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons.Glutamate receptor subtypes mediating synaptic activation of prefrontal cortex neurons: relevance for schizophreniaRole of Thalamic Projection in NMDA Receptor-Induced Disruption of Cortical Slow Oscillation and Short-Term Plasticity.The hippocampo-prefrontal pathway: a possible therapeutic target for negative and cognitive symptoms of schizophreniaAntipsychotic drugs reverse the disruption in prefrontal cortex function produced by NMDA receptor blockade with phencyclidine.Afferent drive of medial prefrontal cortex by hippocampus and amygdala is altered in MAM-treated rats: evidence for interneuron dysfunction.Distinct cortical and striatal actions of a β-arrestin-biased dopamine D2 receptor ligand reveal unique antipsychotic-like properties.THC and endocannabinoids differentially regulate neuronal activity in the prefrontal cortex and hippocampus in the subchronic PCP model of schizophrenia.Losing your inhibition: linking cortical GABAergic interneurons to schizophrenia.Ketamine disrupts θ modulation of γ in a computer model of hippocampus.Phencyclidine administration during neurodevelopment alters network activity in prefrontal cortex and hippocampus in adult rats.Impulsive behaviour induced by both NMDA receptor antagonism and GABAA receptor activation in rat ventromedial prefrontal cortex.Differential Effects of Anaesthesia on the phMRI Response to Acute Ketamine Challenge.The 5-HT receptor antagonist M100,907 prevents extracellular glutamate rising in response to NMDA receptor blockade in the mPFC.Subanalgesic ketamine enhances morphine-induced antinociceptive activity without cortical dysfunction in rats.Activation of medial prefrontal cortex by phencyclidine is mediated via a hippocampo-prefrontal pathway.Effects of aripiprazole, olanzapine, and haloperidol in a model of cognitive deficit of schizophrenia in rats: relationship with glutamate release in the medial prefrontal cortex.Effects of Hallucinogens on Neuronal Activity.Role of mGlu5 Receptors and Inhibitory Neurotransmission in M1 Dependent Muscarinic LTD in the Prefrontal Cortex: Implications in Schizophrenia.Antipsychotic drugs reverse the AMPA receptor-stimulated release of 5-HT in the medial prefrontal cortex.Hypofunction of prefrontal cortex NMDA receptors does not change stress-induced release of dopamine and noradrenaline in amygdala but disrupts aversive memory.Modulation of hippocampus-prefrontal cortex synaptic transmission and disruption of executive cognitive functions by MK-801.Bidirectional variation in glutamate efflux in the medial prefrontal cortex induced by selective positive and negative allosteric mGluR5 modulators.
P2860
Q24597790-F9C33760-3C04-4FD2-BF15-1EA55D229E39Q27311282-3BE0F52C-63F7-4988-863A-37C36E912158Q30355619-CDB05127-BB5E-40BF-84B6-31C2ED6A1B6CQ30830269-65CA35EE-2147-4F54-BCA5-0048C5AC6E1FQ33768048-35EBCAC3-CD74-4B1B-BDC6-060E727F6942Q34197064-7B1B7569-3984-45CB-B47E-4C026915ADCEQ34583614-871D500B-EAE8-47F8-830E-1B45317F73CFQ34953049-9C261654-9910-4ED4-B910-ED9297EF8194Q35222750-E5F9C1CD-E247-4C9A-AACF-B5541EF0092AQ35990236-A95E5170-2E7A-4160-9494-4C45BF969865Q37103350-0AFC457E-A333-42F7-8D80-347A32A21072Q37515058-14C4ADD9-D0CE-41FC-9D90-29EC43156DDBQ37597632-80B9E328-C890-49E6-91F5-68A5A94135C7Q38064198-739DECF5-9018-4C19-99EF-3FDE81D148EEQ38537612-4975A970-B0E4-47B8-A001-A9A3C22D62A7Q38766481-D84318E0-AED5-47B3-95B5-F09D5C1B33CCQ40086305-259706CD-4E68-4A44-B552-56A0756C3BD5Q42105125-47E08282-C151-4083-9D3C-008CC42BE74AQ42467912-E640FCFF-F822-4DF6-9BA7-BC4D717D3712Q44128577-EAF6C24D-B6A4-47B5-9518-3330F903E893Q45040879-6D6149AF-D574-4E1B-93C7-25FAD3BBB926Q46927168-837CEE82-B4FE-4783-B4BE-40838792C5CBQ47791105-0FFDA413-70F9-40E9-AEBD-6B9528C19F1DQ47836225-257E8403-CD7E-4DAF-9C10-62A5D0585E27Q48224639-DE4A65FC-3179-4B11-BCFF-5A63B0000C87Q48295736-2B24B990-7992-4296-B8BE-87555656BE6CQ48826928-36E6B19E-2725-4137-ABFC-A91571A30D9CQ50119965-4941E223-D89F-4D1E-851D-9F4A2BD3F0D3
P2860
Acute administration of phencyclidine induces tonic activation of medial prefrontal cortex neurons in freely moving rats.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
name
Acute administration of phency ...... neurons in freely moving rats.
@ast
Acute administration of phency ...... neurons in freely moving rats.
@en
Acute administration of phency ...... neurons in freely moving rats.
@nl
type
label
Acute administration of phency ...... neurons in freely moving rats.
@ast
Acute administration of phency ...... neurons in freely moving rats.
@en
Acute administration of phency ...... neurons in freely moving rats.
@nl
prefLabel
Acute administration of phency ...... neurons in freely moving rats.
@ast
Acute administration of phency ...... neurons in freely moving rats.
@en
Acute administration of phency ...... neurons in freely moving rats.
@nl
P2093
P1433
P1476
Acute administration of phency ...... neurons in freely moving rats.
@en
P2093
P304
P356
10.1016/S0306-4522(02)00298-1
P407
P577
2002-01-01T00:00:00Z